Dynamic Technology Lab’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,053
Closed -$536K 1281
2024
Q3
$536K Buy
35,053
+17,331
+98% +$273K 0.06% 547
2024
Q2
$270K Buy
+17,722
New +$286K 0.03% 708
2023
Q1
Sell
-22,830
Closed -$472K 1441
2022
Q4
$472K Buy
+22,830
New +$628K 0.05% 601
2021
Q2
Sell
-7,161
Closed -$201K 1456
2021
Q1
$201K Sell
7,161
-1,182
-14% -$41.1K 0.02% 955
2020
Q4
$217K Sell
8,343
-8,296
-50% -$201K 0.04% 796
2020
Q3
$285K Buy
16,639
+299
+2% +$6.68K 0.05% 680
2020
Q2
$404K Buy
+16,340
New +$441K 0.06% 539

Other funds holding RCUS

Dynamic Technology Lab's RCUS Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 35,053 shares — an estimated $536K sold.

Dynamic Technology Lab first reported a position in RCUS in Q2 2020 and held it in 7 quarters. The position peaked at $536K in Q3 2024. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 35,053 Arcus Biosciences shares in Q4 2024, an estimated $536K.
  • Dynamic Technology Lab first reported a position in Arcus Biosciences in Q2 2020 and held it in 7 quarters.
  • Dynamic Technology Lab's Arcus Biosciences position peaked at $536K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.